These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 23924894

  • 1. Synthesis and biological evaluation of novel benzyl piperazine derivatives of 5-(5-nitroaryl)-1,3,4-thiadiazoles as Anti-Helicobacter pylori agents.
    Mohammadhosseini N, Saniee P, Ghamaripour A, Aryapour H, Afshar F, Edraki N, Siavoshi F, Foroumadi A, Shafiee A.
    Daru; 2013 Aug 08; 21(1):66. PubMed ID: 23924894
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 2-Substituted-5-nitroheterocycles: in vitro anti-Helicobacter pylori activity and structure-activity relationship study.
    Foroumadi A, Sorkhi M, Moshafi MH, Safavi M, Rineh A, Siavoshi F, Shafiee A, Emami S.
    Med Chem; 2009 Nov 08; 5(6):529-34. PubMed ID: 19673692
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents.
    Moshafi MH, Sorkhi M, Emami S, Nakhjiri M, Yahya-Meymandi A, Negahbani AS, Siavoshi F, Omrani M, Alipour E, Vosooghi M, Shafiee A, Foroumadi A.
    Arch Pharm (Weinheim); 2011 Mar 08; 344(3):178-83. PubMed ID: 21384417
    [Abstract] [Full Text] [Related]

  • 6. Synthesis of new 2-(5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-ylimino)thiazolidin-4-one derivatives as anti-MRSA and anti-H. pylori agents.
    Tabei A, Ejtemaei R, Mahboubi A, Saniee P, Foroumadi A, Dehdari A, Almasirad A.
    BMC Chem; 2022 May 27; 16(1):38. PubMed ID: 35624517
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-activity relationship study of a series of N-substituted piperazinyl-fluoroquinolones as anti-Helicobacter pylori agents.
    Foroumadi A, Safavi M, Emami S, Siavoshi F, Najjari S, Safari F, Shafiee A.
    Med Chem; 2008 Sep 27; 4(5):498-502. PubMed ID: 18782047
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and antibacterial activity of nitroaryl thiadiazole-gatifloxacin hybrids.
    Jazayeri S, Moshafi MH, Firoozpour L, Emami S, Rajabalian S, Haddad M, Pahlavanzadeh F, Esnaashari M, Shafiee A, Foroumadi A.
    Eur J Med Chem; 2009 Mar 27; 44(3):1205-9. PubMed ID: 18950903
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles.
    Alipour E, Emami S, Yahya-Meymandi A, Nakhjiri M, Johari F, Ardestani SK, Poorrajab F, Hosseini M, Shafiee A, Foroumadi A.
    J Enzyme Inhib Med Chem; 2011 Feb 27; 26(1):123-8. PubMed ID: 20578974
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and antibacterial activity of nitroaryl thiadiazole-levofloxacin hybrids.
    Foroumadi A, Mansouri S, Emami S, Mirzaei J, Sorkhi M, Saeid-Adeli N, Shafiee A.
    Arch Pharm (Weinheim); 2006 Nov 27; 339(11):621-4. PubMed ID: 17036368
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and Leishmanicidal Activity of 1-[5-(5-Nitrofuran-2-yl)-1, 3, 4-Thiadiazole-2-yl]-4-BenzoylePiperazines.
    Foroumadi A, Adibi H, Kabudanian Ardestani S, Shirooie S, Bozorgomid A, Jafari A.
    Iran J Pharm Res; 2017 Nov 27; 16(3):904-909. PubMed ID: 29201081
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moieties.
    Tahghighi A, Razmi S, Mahdavi M, Foroumadi P, Ardestani SK, Emami S, Kobarfard F, Dastmalchi S, Shafiee A, Foroumadi A.
    Eur J Med Chem; 2012 Apr 27; 50():124-8. PubMed ID: 22336386
    [Abstract] [Full Text] [Related]

  • 15. New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity.
    Tahghighi A, Emami S, Razmi S, Rezazade Marznaki F, Kabudanian Ardestani S, Dastmalchi S, Kobarfard F, Shafiee A, Foroumadi A.
    J Enzyme Inhib Med Chem; 2013 Aug 27; 28(4):843-52. PubMed ID: 22651800
    [Abstract] [Full Text] [Related]

  • 16. A Novel Method for the Syntheses of Imidazo-Thiadiazoles as Potential Antioxidants and Anti-Inflammatory Agents.
    Raut DG, Bhosale RB, Lawand AS, Hublikar MG, Kadu VD, Patil SB.
    Recent Adv Inflamm Allergy Drug Discov; 2022 Aug 27; 16(1):19-25. PubMed ID: 35410625
    [Abstract] [Full Text] [Related]

  • 17. Anti-Helicobacter pylori potential of artemisinin and its derivatives.
    Goswami S, Bhakuni RS, Chinniah A, Pal A, Kar SK, Das PK.
    Antimicrob Agents Chemother; 2012 Sep 27; 56(9):4594-607. PubMed ID: 22687518
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and Docking Study of Novel 4-Thiazolidinone Derivatives as Anti-Gram-positive and Anti-H. pylori Agents.
    Khomami A, Rahimi M, Tabei A, Saniee P, Mahboubi A, Foroumadi A, Koopaei NN, Almasirad A.
    Mini Rev Med Chem; 2019 Sep 27; 19(3):239-249. PubMed ID: 30332951
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of Helicobacter pylori to metronidazole.
    Perna F, Gatta L, Figura N, Ricci C, Tampieri A, Holton J, Miglioli M, Vaira D.
    Am J Gastroenterol; 2003 Oct 27; 98(10):2157-61. PubMed ID: 14572561
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, Anticancer, Antimicrobial and Antioxidant Potential of Novel 4-(Substituted phenyl-1,3,4-oxadiazol/thiadiazol-2-yl)-4-(4-substituted phenyl) Azetidin-2-One Derivatives.
    Kumar D, Aggarwal N, Kumar V, Kumar H, Deep A, Bibi S, Chopra H, Kumar Marwaha R, Alshammari A, Alharbi M, Hayee A.
    Pharmaceuticals (Basel); 2023 Mar 30; 16(4):. PubMed ID: 37111274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.